Close menu




BAYER AG NA O.N.

Photo credits: pixabay.com

Commented by Nico Popp on March 22nd, 2022 | 11:22 CET

In the right place at the right time: BioNTech, Defence Therapeutics, Bayer

  • Biotechnology

For years, the pandemic has kept the world on tenterhooks. Currently, the epidemic is taking a break, at least in the media. But while the world is looking tautly at Ukraine and more and more refugees are arriving in Germany, the Omicron figures are rising once more. In some cases, the incidence in Germany is over 3,000. Although fewer and fewer people are dying, more people than ever are in quarantine. We look at BioNTech, a typical pandemic stock, and present other exciting investments from the healthcare sector.

Read

Commented by Carsten Mainitz on March 16th, 2022 | 11:18 CET

Valneva, Perimeter Medical Imaging AI, Bayer - Immune to the crisis?

  • medtech

No sooner did the Corona pandemic seem to be under control than the world was shocked by the invasion of Russian troops in Ukraine. So far, the stock markets have digested the whole situation well. But even without further escalation, the supply situation for raw materials, among other things, will become more complex. The first signs are already awaiting us at the gas pumps. The rise in inflation will continue. Where should one invest given this mixed situation? Regardless of the economic and security situation, stocks from the healthcare sector are a good choice. Beyond fighting viruses or infectious diseases, there are great growth areas. Cancer is one such area. In addition, medical technology is increasingly bringing innovative technologies to the market, in some cases in conjunction with artificial intelligence, with disruption potential.

Read

Commented by Juliane Zielonka on March 15th, 2022 | 13:19 CET

BASF, Almonty Industries, Bayer - These stocks are providing the momentum

  • Tungsten

New battery technology from BASF promises faster charging times. The Ludwigshafen-based conglomerate talks of 15 minutes for charging an e-car with a 600km range. New batteries require the appropriate materials, such as the element tungsten. In this area, Almonty Industries provides supplies thanks to its resource-rich mine in South Korea. Meanwhile, Bayer AG in Leverkusen is busy shrinking itself back to health. Bayer's stock has been rising somewhat since it was announced that it was divesting its pest control division.

Read

Commented by Carsten Mainitz on March 11th, 2022 | 11:35 CET

Saturn Oil + Gas, BYD, Bayer - Winning with strong companies

  • Oil
  • Electromobility

When oil futures were trading in negative territory even for a short time at the outbreak of the Corona pandemic in the spring of 2020, many experts assumed that the black gold would remain at a low level in the long term. Only JPMorgan spoke at that time of a possible supercycle and prices over USD 100 per barrel. The analysts cited the supply shortage due to the swing towards green energy production as the reason. Due to the Ukraine crisis, supply has once again been drastically reduced, which is likely to fuel oil prices in the long term.

Read

Commented by Stefan Feulner on March 4th, 2022 | 13:33 CET

Bayer, Defence Therapeutics, Merck KGaA - At the start of the trend

  • Biotechnology

The biotech industry is the innovative engine for a pharmaceutical industry dependent on new concepts due to the shift from blockbuster products to personalized medicine. Even before Corona, more than EUR seven billion per year was invested in R&D in 2019. The development of new drugs is particularly important for the pharmaceutical industry, as patent protection for many blockbuster drugs is expiring or has already expired. For this reason, the pharmaceutical industry is now much more often entering biotech companies in the early development phases of a new drug. The example of vaccine manufacturers has successfully highlighted this strategy, which will also be applied to other diseases in the future.

Read

Commented by Stefan Feulner on March 2nd, 2022 | 11:31 CET

Bayer, Desert Gold, K+S - Market facing redistribution

  • Gold

Since Russia invaded Ukraine last week, the world has literally been turned upside down. There is bewilderment at the violence of the Russian president. Western nations are responding with sanctions against Russia, such as excluding Russian banks from the SWIFT system. In addition, the plan is to extend sanctions to other companies in various industries. Companies that are not affected benefit from this and gain market share. For example, the fertilizer industry is facing a redistribution of market conditions in favor of German suppliers.

Read

Commented by Carsten Mainitz on February 22nd, 2022 | 10:49 CET

Bayer, Memiontec, Dr. Hönle - Serious threat!

  • Investments

Water is the basis of all life. We use water for our nutrition, daily hygiene and leisure activities. Water is also a crucial economic factor as an energy source, transport medium and raw material. But access to clean drinking water is not a matter of course; even today, 1 billion people are denied it. According to various experts, this situation will soon deteriorate dramatically. By 2025, 3 billion people could be living in countries with severe water shortages. Therefore, water scarcity is an urgent issue for the future of humanity.

Read

Commented by Carsten Mainitz on February 18th, 2022 | 12:47 CET

Commerzbank, wallstreet:online, Bayer - Positive signals!

  • Investments

The US Federal Reserve is on the verge of ending its ultra-loose monetary policy and is signaling interest rate hikes soon in order to get a grip on high inflation, which is currently far above the target value of 2%. In addition, the monetary watchdogs cite future inflation risks and the robust labor market as reasons for the rising interest rates. As a result, shares of banks and financial services providers are benefiting. The successful restructuring measures, which are now generating billions in profits for the banks, also boost share prices.

Read

Commented by Juliane Zielonka on February 17th, 2022 | 12:10 CET

Peloton, Diamcor, Bayer - Trust, tangibles and expertise

  • Diamonds

Peloton gets in shape with streamlining just like its existing customers. 90% of early adopters remain loyal to the Company. Rough diamonds achieve new record prices, Diamcor profits, and so do its investors. Bayer comes up trumps in the agricultural business with innovative solutions for corn cultivation. In the upcoming market phase, investors want to be prepared. Investing in price-setters that take advantage of strong inflation makes sense. We take a look at three investment opportunities.

Read

Commented by Armin Schulz on February 7th, 2022 | 12:14 CET

Bayer, Perimeter Medical Imaging AI, Siemens Healthineers - Diagnostics as an upcoming trend in the pharmaceutical industry

  • medtech

The Corona pandemic has made many people aware of the importance of diagnostics. Without PCR and antigen tests, it would have been impossible to control the incidence of infection. But it is not only in this area that things have changed in the last 2 years. Diagnostics are becoming increasingly digitized, and so more and more tech companies are entering the market that originally had nothing to do with the pharmaceutical industry. The better the diagnostics, the earlier diseases can be detected and treated. It is a future topic in pharma. We look at three companies from this sector today.

Read